| Michael J Stanek, DO | |
|
2946 E Banner Gateway Dr, Gilbert, AZ 85234-2165 | |
| (480) 256-4094 | |
| (480) 256-4683 |
| Full Name | Michael J Stanek |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 49 Years |
| Location | 2946 E Banner Gateway Dr, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275541401 | NPI | - | NPPES |
| 0756829 | Medicaid | OH | |
| 266225 | Medicaid | AZ | |
| 4757290 | Other | AZ | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 34004882 (Ohio) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4598 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Cancer Center Specialists Llc | 6103097779 | 266 |
News Archive
Recent U.N. statistics showing a drop in child mortality are both good and bad, because the number of child deaths continues to drop, but "progress isn't reaching all families around the world, and it isn't reaching newborn babies as often as older children," Joy Lawn, director of Global Evidence and Policy for Save the Children's Saving Newborn Lives program, writes in a GlobalPost opinion piece.
MicroRNAs are interesting target structures for new therapeutic agents. They can be blocked through synthetic antimiRs.
Researchers at Children's Hospital Los Angeles have discovered that by targeting a particular receptor, chemotherapy-resistant cancer cells can be killed in an acute form of childhood leukemia, offering the potential for a future treatment for patients who would otherwise experience relapse of their disease.
Zoning restrictions on fast-food restaurants near schools and playgrounds, community policing to improve safety around public recreational sites, requirements that publicly run after-school programs limit video game and TV time, and taxes on high-calorie, low-nutrient foods and drinks are some of the strategies local government officials can use to tackle the childhood obesity epidemic in their communities, says a new report from the Institute of Medicine and National Research Council.
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia.
› Verified 4 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
Recent U.N. statistics showing a drop in child mortality are both good and bad, because the number of child deaths continues to drop, but "progress isn't reaching all families around the world, and it isn't reaching newborn babies as often as older children," Joy Lawn, director of Global Evidence and Policy for Save the Children's Saving Newborn Lives program, writes in a GlobalPost opinion piece.
MicroRNAs are interesting target structures for new therapeutic agents. They can be blocked through synthetic antimiRs.
Researchers at Children's Hospital Los Angeles have discovered that by targeting a particular receptor, chemotherapy-resistant cancer cells can be killed in an acute form of childhood leukemia, offering the potential for a future treatment for patients who would otherwise experience relapse of their disease.
Zoning restrictions on fast-food restaurants near schools and playgrounds, community policing to improve safety around public recreational sites, requirements that publicly run after-school programs limit video game and TV time, and taxes on high-calorie, low-nutrient foods and drinks are some of the strategies local government officials can use to tackle the childhood obesity epidemic in their communities, says a new report from the Institute of Medicine and National Research Council.
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Stanek, DO 2946 E. Banner Gateway Drive, Attn: Payer Contracting & Relations, Gilbert, AZ 85234 Ph: (480) 256-4094 | Michael J Stanek, DO 2946 E Banner Gateway Dr, Gilbert, AZ 85234-2165 Ph: (480) 256-4094 |
News Archive
Recent U.N. statistics showing a drop in child mortality are both good and bad, because the number of child deaths continues to drop, but "progress isn't reaching all families around the world, and it isn't reaching newborn babies as often as older children," Joy Lawn, director of Global Evidence and Policy for Save the Children's Saving Newborn Lives program, writes in a GlobalPost opinion piece.
MicroRNAs are interesting target structures for new therapeutic agents. They can be blocked through synthetic antimiRs.
Researchers at Children's Hospital Los Angeles have discovered that by targeting a particular receptor, chemotherapy-resistant cancer cells can be killed in an acute form of childhood leukemia, offering the potential for a future treatment for patients who would otherwise experience relapse of their disease.
Zoning restrictions on fast-food restaurants near schools and playgrounds, community policing to improve safety around public recreational sites, requirements that publicly run after-school programs limit video game and TV time, and taxes on high-calorie, low-nutrient foods and drinks are some of the strategies local government officials can use to tackle the childhood obesity epidemic in their communities, says a new report from the Institute of Medicine and National Research Council.
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia.
› Verified 4 days ago
Sandhyaben P Patel, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1900 N Higley Rd, Gilbert, AZ 85234 Phone: 480-543-2134 Fax: 480-512-6089 | |
Dr. Shivakumar Vignesh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr., Suite 400, Gilbert, AZ 85234 Phone: 480-256-3332 Fax: 813-449-8028 | |
Dr. Noreen Catherine Ruane, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3555 S Val Vista Dr, Gilbert, AZ 85297 Phone: 602-933-0777 Fax: 602-933-0755 | |
Dr. Ala Eddin Samir Sagar, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2940 E Banner Gateway Drive, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 | |
Theresa Ong Liu Dumlao, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Suite 450, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-4683 | |
Dr. Zachary Phillip Yeung, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-245-6444 Fax: 480-256-4623 | |
Richard D Sue, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2946 E Banner Gateway Dr, Gilbert, AZ 85234 Phone: 480-256-6444 Fax: 480-256-3682 |